.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,342,530

« Back to Dashboard

Claims for Patent: 6,342,530

Title: Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
Abstract:Pharmaceutical compositions are disclosed suitable for parenteral administration having anti-inflammatory, analgesic, and anti-pyretic properties, which consist of a therapeutically effective amount of d,l or l-lysine salt of R,S or S-ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and either substantially free or absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere. Also disclosed are methods employing the new compositions in the treatment of pain and inflammation, in reducing fever and in treating patent ductus arterious or intraventricular hemorrhage in prematurely born neonates.
Inventor(s): Darko; Laszlo (Westport, CT)
Assignee: Farmacon-Il, LLC (Westport, CT)
Application Number:09/712,430
Patent Claims: 1. A pharmaceutical composition in unit dosage form in a vial or ampoule having excellent storage stability over a period of 2 years and suitable for parenteral administration having anti-inflammatory, anti-pyretic and analgesic properties, which consists of a therapeutically effective amount of the d,l or l-lysine salt of R,S or S- ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and substantially free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere.

2. A method of treating pain or inflammation or of reducing fever in a mammalian subject which comprises the step of parenterally administering to said mammalian subject, a therapeutically effective amount of the pharmaceutical composition defined in claim 1.

3. The method of treating pain or inflammation or of reducing fever defined in claim 2 wherein the mammalian subject is a human patient.

4. The method of treating pain or inflammation or of reducing fever defined in claim 3 wherein the human patient is a premature neonate.

5. The method of treating pain or inflammation or of reducing fever defined in claim 3 wherein the human patient suffers from kidney disease.

6. The method of treating pain or inflammation or of reducing fever defined in claim 2 wherein the pharmaceutical composition is administered by injection.

7. The method of treating pain or inflammation or of reducing fever defined in claim 6 wherein the injection is intravenous, intramuscular or subcutaneous injection.

8. A method of treating patent ductus arterious or intraventricular hemorrhage in a prematurely born neonate which comprises the step of parenterally administering to said prematurely born neonate, a therapeutically effective amount of the pharmaceutical composition defined in claim 1.

9. A method of preparing the pharmaceutical composition defined in claim 1 which comprises the steps of dissolving the d,l- or l-lysine salt of R,S or S-ibuprofen in sterile water to form a solution in the absence of an inert atmosphere and substantially free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere, adding the solution to a vial or ampoule, and closing the vial or ampoule.

10. A method of preparing the pharmaceutical composition defined in claim which comprises the step of dissolving d,l- or l-lysine and R,S or S-ibuprofen in sterile water to form in situ a solution of the d,l- or l-lysine salt of R,S or S-ibuprofen in the absence of an inert atmosphere and substantially free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere, adding the solution to a vial or ampoule, and closing the vial or ampoule.

11. A pharmaceutical composition in unit dosage form in a vial or ampoule shaving excellent storage stability over a period of 2 years and suitable for parenteral administration having anti-inflammatory, anti-pyretic and analgesic properties, which consists of a therapeutically effective amount of the d,l or l-lysine salt of R,S or S- ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere.

12. A method of treating pain or inflammation or of reducing fever in a mammalian subject which comprises the step of parenterally administering to said mammalian subject, a therapeutically effective amount of the pharmaceutical composition defined in claim 11.

13. The method of treating pain or inflammation or of reducing fever defined in claim 12 wherein the mammalian subject is a human patient.

14. The method of treating pain or inflammation or of reducing fever defined in claim 13 wherein the human patient is a premature neonate.

15. The method of treating pain or inflammation or of reducing fever defined in claim 13 wherein the human patient suffers from kidney disease.

16. The method of treating pain or inflammation or of reducing fever defined in claim 12 wherein the pharmaceutical composition is administered by injection.

17. The method of treating pain or inflammation or of reducing fever defined in claim 16 wherein the injection is intravenous, intramuscular or subcutaneous injection.

18. A method of treating patent ductus arterious or intraventricular hemorrhage in a prematurely born neonate which comprises the step of parenterally administering to said prematurely born neonate, a therapeutically effective amount of the pharmaceutical composition defined in claim 11.

19. A method of preparing the pharmaceutical composition defined in claim 11 which comprises the steps of dissolving the d,l- or l-lysine salt of R,S or S-ibuprofen in sterile water to form a solution in the absence of an inert atmosphere and absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere, adding the solution to a vial or ampoule, and closing the vial or ampoule.

20. A method of preparing the pharmaceutical composition defined in claim 11 which comprises the steps of dissolving d,l- or l-lysine and R,S or S-ibuprofen in sterile water to form in situ a solution of the d,l- or l-lysine salt of R,S or S-ibuprofen in the absence of an inert atmosphere and absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere, adding the solution to a vial or ampoule, and closing the vial or ampoule.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc